NPRA mission is to safeguard the nation’s health through scientific excellence in the regulatory control of medicinal products and cosmetics.
COVID-19
PRODUCT SEARCH
REPORTING OF SIDE EFFECTS TO MEDICINES OR VACCINES
[Updated] Pholcodine: Risk of Anaphylaxis to Neuromuscular Blocking Agents (NMBAs) |
Topiramate: Neurodevelopmental Disorders in Children Exposed to Topiramate During Pregnancy |
Approved Clinical Trial Import License & Clinical Trial Exemption (CTX) Application |
Declaration of Worldwide Registration Status for Generic Medicines in QUEST System |
Change of Venue for the National Regulatory Conference (NRC) 2023 to M Resort & Hotel, Kuala Lumpur |
14 Nov 2022; 08:00AM - 05:00PM MOPI Virtual Training : Good Distribution Practice for the Regulated Industry |
03 Nov 2022; 08:00AM - 05:00PM MOPI Virtual Training : Contamination Control |
17 Oct 2022; 08:00AM - 05:00PM MOPI Virtual Training : Internal Audit - a key to effective Quality System |
19 Sep 2022; 08:00AM - 05:00PM MOPI Virtual Training : Behavioural GMP - mininising human error |
22 Aug 2022; 08:00AM - 05:00PM MOPI Virtual Training : Cleaning Validation |